Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda

Table 3

Age wise Prevalence of anti-HCV antibodies and HCV RNA among study participants.

Age group (yrs)	Number of participants	Anti-HCV +ve	HCV RNA
18–35	123	8 (6.5%)	3 (2.4%)
36–55	134	16 (11.9%)	9 (6.7%)
>55	67	28 (41.8%)	19 (28.4%)
Total	324	52 (16.0%)	31 (9.6%)